Wednesday, April 6, 2022

M&MFIN

M&MFIN(Mahindra & Mahindra Financial Services Limited)

05.01.2023 - MS on M&MFin Maintain Overweight CMP 232.9 Target 275
03.01.2023 - Jefferies on M&MFIN Maintain Underperform CMP 232.9 Target 175
03.12.2022 - MS on M&MFIN Maintain Overweight CMP 229.9 Target 275
03.12.2022 - CLSA on M&MFIN Maintain Buy CMP 229.9 Target 260
04.11.2022 - Nomura on M&MFIN Maintain Neutral CMP 217.5 Target 210
03.11.2022 - Jefferies on M&MFIN Maintain Underperform CMP 218.95 Target 155
03.11.2022 - BOFA on M&MFIN Maintain Buy CMP 218.95 Target 245
03.11.2022 - MS on M&MFIN Maintain Overweight CMP 218.95 Target 225
04.10.2022 - MS on M&MFIN Maintain Overweight CMP 199.2 Target 225
04.10.2022 - BOFA on M&MFIN Maintain Buy CMP 199.2 Target 245
23.09.2022 - MS on M&MFIN Maintain Overweight CMP 180.3 Target 225
20.09.2022 - CLSA on M&M Maintain Buy CMP 227.6 Target 260

01.08.2022 - CS on M&MFIN Maintain Underperform CMP 189.95 Target 157
29.07.2022 - MS on M&MFIN Maintain Overweight CMP 186.8 Target 225
05.07.2022 - MS on M&MFIN Maintain Overweight CMP 178.85 Target 225
06.06.2022 - BOFA on M&MFIN Maintain Buy CMP 186.4 Target 206
05.04.2022 - BOFA on M&MFIN Maintain Buy CMP 168.10 Target 188
03.02.2022 - CLSA on M&MFIN Maintain Outperform CMP 169 Target 240

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830